Reversible Acute Renal Failure Induced by Losartan in a Renal Transplant Recipient
Overview
Affiliations
A 56-year-old man who received a live-related renal transplant in 1988 was started in 1995 on the selective angiotensin II antagonist losartan (Dupont-Merke) to treat worsening hypertension. Two months later because of pulmonary oedema, loop diuretics were started. Within two weeks, serum creatinine had increased from 245 to 571 mumol/l, and the patient became oliguric. A systolic bruit was noted over the graft. Renal angiography showed a 90% stenosis of the transplant renal artery. Losartan was withdrawn, with prompt improvement in renal function. A successful percutaneous transluminal angioplasty performed a few days later resulted in further improvement in renal function accompanied by a significant diuresis.
Utilisation and Tolerability of Aliskiren in the Primary Care Setting in England.
Coughtrie A, Doe C, Layton D, Shakir S J Clin Hypertens (Greenwich). 2016; 18(12):1237-1243.
PMID: 27255757 PMC: 8031493. DOI: 10.1111/jch.12852.
Johansen T, Kjaer A BMC Nephrol. 2001; 2:1.
PMID: 11388887 PMC: 32190. DOI: 10.1186/1471-2369-2-1.
Scoble J J R Soc Med. 2000; 92(10):505-10.
PMID: 10692901 PMC: 1297389. DOI: 10.1177/014107689909201004.